Measles

Displaying 1 - 5 of 5CSV
Schmitz, K. S., Handrejk, K., Liepina, L., Bauer, L., Haas, G. D., van Puijfelik, F., Veldhuis Kroeze, E. J. B., Riekstina, M., Strautmanis, J., Cao, H., Verdijk, R. M., GeurtsvanKessel, C. H., van Boheemen, S., van Riel, D., Lee, B., Porotto, M., de Swart, R. L., & de Vries, R. D. (2024). Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments. Journal of Virology, 98(3). https://doi.org/10.1128/jvi.01874-23
Publication Date
Ferren, M., Lalande, A., Iampietro, M., Canus, L., Decimo, D., Gerlier, D., Porotto, M., & Mathieu, C. (2023). Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure. Viruses, 15(1), 229. https://doi.org/10.3390/v15010229
Publication Date
Reynard, O., Gonzalez, C., Dumont, C., Iampietro, M., Ferren, M., Le Guellec, S., Laurie, L., Mathieu, C., Carpentier, G., Roseau, G., Bovier, F. T., Zhu, Y., Le Pennec, D., Montharu, J., Addetia, A., Greninger, A. L., Alabi, C. A., Brisebard, E., Moscona, A., … Horvat, B. (2022). Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33832-6
Publication Date
Schmitz, K. S., Lange, M. V., Gommers, L., Handrejk, K., Porter, D. P., Alabi, C. A., Moscona, A., Porotto, M., de Vries, R. D., & de Swart, R. L. (2022). Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds. Viruses, 14(6), 1186. https://doi.org/10.3390/v14061186
Publication Date